Kornélia Baghy Selected Research

Decorin

1/2020	Decorin in the Tumor Microenvironment.
1/2020	Protective Role of Decorin in Primary Hepatocellular Carcinoma.
1/2020	The Protective Role of Decorin in Hepatic Metastasis of Colorectal Carcinoma.
10/2019	Tumor-specific inhibitory action of decorin on different hepatoma cell lines.
4/2014	Decorin deficiency promotes hepatic carcinogenesis.
5/2013	Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis.
4/2012	Decorin-TGFβ axis in hepatic fibrosis and cirrhosis.
3/2011	Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kornélia Baghy Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 01/2012
8	Liver Neoplasms (Liver Cancer) 01/2022 - 05/2013
7	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2013
7	Carcinogenesis 01/2022 - 04/2014
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 03/2011
4	Fibrosis (Cirrhosis) 03/2021 - 03/2011
3	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2012
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2015
2	Liver Diseases (Liver Disease) 01/2022 - 04/2020
2	Hepatitis C 01/2022 - 11/2014
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Adenocarcinoma 01/2021 - 01/2018
2	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2016 - 03/2014
1	Pathologic Processes 01/2022
1	Non-alcoholic Fatty Liver Disease 03/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Carcinoma (Carcinomatosis) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Adenocarcinoma of Lung 01/2018
1	Pituitary Neoplasms (Pituitary Adenoma) 07/2017
1	Adenoma (Adenomas) 07/2017
1	Urachal cancer 06/2016
1	Disease Progression 07/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015
1	Hyperglycemia 01/2015
1	Adrenocortical Carcinoma 01/2015
1	Chronic Hepatitis C 11/2014
1	Hepatoblastoma 11/2014

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2007
8	DecorinIBA 01/2020 - 03/2011
6	Phosphotransferases (Kinase)IBA 01/2020 - 05/2013
5	Syndecan-1 (Syndecan 1)IBA 01/2022 - 01/2012
5	Small Leucine-Rich ProteoglycansIBA 01/2020 - 03/2011
4	tyrosine receptor (receptor, tyrosine)IBA 01/2020 - 05/2013
4	MicroRNAs (MicroRNA)IBA 07/2017 - 11/2014
3	Proteoglycans (Proteoglycan)IBA 01/2022 - 01/2016
3	CateninsIBA 03/2021 - 04/2014
2	Heparitin Sulfate (Heparan Sulfate)IBA 01/2022 - 01/2014
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 03/2021 - 01/2018
2	Conditioned Culture MediaIBA 01/2020 - 01/2015
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020 - 05/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2015
2	Pharmaceutical PreparationsIBA 01/2016 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 07/2015
2	CollagenIBA 04/2015 - 03/2011
2	Messenger RNA (mRNA)IBA 01/2015 - 03/2011
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Chondroitin Sulfate ProteoglycansIBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 03/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	PlatinumIBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	AndrogensIBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	Codon (Codons)IBA 01/2019
1	balanophoninIBA 06/2018
1	Keratin-7 (Cytokeratin 7)IBA 01/2018
1	Thioacetamide (Thioacetamid)IBA 01/2018
1	CarcinogensIBA 01/2018
1	AgrinIBA 01/2016
1	Versicans (Versican)IBA 01/2016
1	GlypicansIBA 01/2016
1	Fibronectins (Fibronectin)IBA 04/2015
1	Laminin (Merosin)IBA 04/2015
1	laminin 1IBA 04/2015
1	IntegrinsIBA 04/2015
1	Laminin ReceptorsIBA 04/2015
1	LigandsIBA 01/2015
1	EnzymesIBA 01/2015
1	LignansIBA 01/2015
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2015
1	trachelogeninIBA 01/2015
1	Mitotane (Lysodren)FDA Link 01/2015
1	CholesterolIBA 11/2014
1	ParaffinIBA 11/2014
1	Formaldehyde (Formol)FDA Link 11/2014
1	RNA (Ribonucleic Acid)IBA 11/2014
1	Claudin-1IBA 11/2014
1	MARVEL Domain Containing 2 ProteinIBA 11/2014
1	NitrosaminesIBA 04/2014
1	Antineoplastic Agents (Antineoplastics)IBA 04/2014
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2014
1	Retinoid X Receptors (Retinoid X Receptor)IBA 03/2014
1	Hormones (Hormone)IBA 03/2014
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2014
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2014
1	Heparin (Liquaemin)FDA LinkGeneric 01/2014
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2014
1	trioctyl phosphine oxide (TOPO)IBA 01/2014
1	Matrilin ProteinsIBA 01/2014
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2014

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2012
1	Castration 01/2021
1	Drug Therapy (Chemotherapy) 01/2021